News
Delivered Q2 2025 revenue of $86 millionQ22025 total test reports for our core revenue drivers (DecisionDx®-Melanoma, TissueCypher®) increased 33% over Q22024Raising full-year 2025 revenue guidance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback